Načítá se...
Incomplete Protection against Dengue Virus Type 2 Re-infection in Peru
BACKGROUND: Nearly half of the world’s population is at risk for dengue, yet no licensed vaccine or anti-viral drug is currently available. Dengue is caused by any of four dengue virus serotypes (DENV-1 through DENV-4), and infection by a DENV serotype is assumed to provide life-long protection agai...
Uloženo v:
| Vydáno v: | PLoS Negl Trop Dis |
|---|---|
| Hlavní autoři: | , , , , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4746126/ https://ncbi.nlm.nih.gov/pubmed/26848841 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pntd.0004398 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|